Abstract
Background: Despite strong evidence linking decreased glomerular filtration rate (GFR) to worse outcomes, the impact of GFR on mortality and morbidity in patients with acute myocardial infarction (AMI) is not well defined. Study Design: Retrospective cohort study. Setting & Participants: 12,636 patients with AMI in the Korea AMI Registry database from November 2005 to July 2008. 93% of patients in this registry had coronary angiography, and 91% of patients with coronary angiography had percutaneous coronary intervention (PCI). Predictor: GFR was estimated (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, and patients were grouped into 5 eGFR categories: >90, 60-89, 30-59, 15-29, and <15 mL/min/1.73 m 2. Outcomes: Primary end points were death and in-hospital complications. Secondary end points were major adverse cardiac events (MACEs) during a 1-month (short-term) and 1-year (long-term) follow-up after AMI. Results: Mean eGFR was 72.8 ± 24.6 mL/min/1.73 m 2, mean age was 64 ± 13 years, and 70.4% were men. A graded association was observed between eGFR and clinical outcomes. In adjusted analyses, compared with eGFR >90 mL/min/1.73 m 2, patients with eGFR of 30-59, 15-29, and <15 mL/min/1.73 m 2 experienced increased risks of short- (respective HRs of 2.30 [95% CI, 1.70-3.11], 3.10 [95% CI, 2.14-4.14], and 3.64 [95% CI, 2.44-5.43]; P < 0.001) and long-term MACEs (HRs of 1.58 [95% CI, 1.32-1.90], 2.12 [95% CI, 1.63-2.75], and 2.50 [95% CI, 1.89-3.29]; P < 0.001). Older age, Killip class higher than I, PCI, and high-sensitivity C-reactive protein level also were associated with higher short- and long-term MACEs. Use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), and statins was associated with decreased risk of MACEs. Limitations: Single assessment of serum creatinine. Conclusion: eGFR was associated independently with mortality and complications after AMI. PCI, β-blocker, ACE inhibitor or ARB, and statin use were associated with decreased risks of short- and long-term MACEs.
| Original language | English |
|---|---|
| Pages (from-to) | 795-802 |
| Number of pages | 8 |
| Journal | American Journal of Kidney Diseases |
| Volume | 59 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2012 Jun 1 |
Fingerprint
Keywords
- Acute myocardial infarction
- glomerular filtration rate
- major adverse cardiac event
ASJC Scopus subject areas
- Nephrology
Cite this
GFR and cardiovascular outcomes after acute myocardial infarction : Results from the Korea acute myocardial infarction registry. / Bae, Eun Hui; Lim, Sang Yeob; Cho, Kyung Hoon; Choi, Joon Seok; Kim, Chang Seong; Park, Jeong Woo; Ma, Seong Kwon; Jeong, Myung Ho; Kim, Soo Wan.
In: American Journal of Kidney Diseases, Vol. 59, No. 6, 01.06.2012, p. 795-802.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - GFR and cardiovascular outcomes after acute myocardial infarction
T2 - Results from the Korea acute myocardial infarction registry
AU - Bae, Eun Hui
AU - Lim, Sang Yeob
AU - Cho, Kyung Hoon
AU - Choi, Joon Seok
AU - Kim, Chang Seong
AU - Park, Jeong Woo
AU - Ma, Seong Kwon
AU - Jeong, Myung Ho
AU - Kim, Soo Wan
PY - 2012/6/1
Y1 - 2012/6/1
N2 - Background: Despite strong evidence linking decreased glomerular filtration rate (GFR) to worse outcomes, the impact of GFR on mortality and morbidity in patients with acute myocardial infarction (AMI) is not well defined. Study Design: Retrospective cohort study. Setting & Participants: 12,636 patients with AMI in the Korea AMI Registry database from November 2005 to July 2008. 93% of patients in this registry had coronary angiography, and 91% of patients with coronary angiography had percutaneous coronary intervention (PCI). Predictor: GFR was estimated (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, and patients were grouped into 5 eGFR categories: >90, 60-89, 30-59, 15-29, and <15 mL/min/1.73 m 2. Outcomes: Primary end points were death and in-hospital complications. Secondary end points were major adverse cardiac events (MACEs) during a 1-month (short-term) and 1-year (long-term) follow-up after AMI. Results: Mean eGFR was 72.8 ± 24.6 mL/min/1.73 m 2, mean age was 64 ± 13 years, and 70.4% were men. A graded association was observed between eGFR and clinical outcomes. In adjusted analyses, compared with eGFR >90 mL/min/1.73 m 2, patients with eGFR of 30-59, 15-29, and <15 mL/min/1.73 m 2 experienced increased risks of short- (respective HRs of 2.30 [95% CI, 1.70-3.11], 3.10 [95% CI, 2.14-4.14], and 3.64 [95% CI, 2.44-5.43]; P < 0.001) and long-term MACEs (HRs of 1.58 [95% CI, 1.32-1.90], 2.12 [95% CI, 1.63-2.75], and 2.50 [95% CI, 1.89-3.29]; P < 0.001). Older age, Killip class higher than I, PCI, and high-sensitivity C-reactive protein level also were associated with higher short- and long-term MACEs. Use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), and statins was associated with decreased risk of MACEs. Limitations: Single assessment of serum creatinine. Conclusion: eGFR was associated independently with mortality and complications after AMI. PCI, β-blocker, ACE inhibitor or ARB, and statin use were associated with decreased risks of short- and long-term MACEs.
AB - Background: Despite strong evidence linking decreased glomerular filtration rate (GFR) to worse outcomes, the impact of GFR on mortality and morbidity in patients with acute myocardial infarction (AMI) is not well defined. Study Design: Retrospective cohort study. Setting & Participants: 12,636 patients with AMI in the Korea AMI Registry database from November 2005 to July 2008. 93% of patients in this registry had coronary angiography, and 91% of patients with coronary angiography had percutaneous coronary intervention (PCI). Predictor: GFR was estimated (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, and patients were grouped into 5 eGFR categories: >90, 60-89, 30-59, 15-29, and <15 mL/min/1.73 m 2. Outcomes: Primary end points were death and in-hospital complications. Secondary end points were major adverse cardiac events (MACEs) during a 1-month (short-term) and 1-year (long-term) follow-up after AMI. Results: Mean eGFR was 72.8 ± 24.6 mL/min/1.73 m 2, mean age was 64 ± 13 years, and 70.4% were men. A graded association was observed between eGFR and clinical outcomes. In adjusted analyses, compared with eGFR >90 mL/min/1.73 m 2, patients with eGFR of 30-59, 15-29, and <15 mL/min/1.73 m 2 experienced increased risks of short- (respective HRs of 2.30 [95% CI, 1.70-3.11], 3.10 [95% CI, 2.14-4.14], and 3.64 [95% CI, 2.44-5.43]; P < 0.001) and long-term MACEs (HRs of 1.58 [95% CI, 1.32-1.90], 2.12 [95% CI, 1.63-2.75], and 2.50 [95% CI, 1.89-3.29]; P < 0.001). Older age, Killip class higher than I, PCI, and high-sensitivity C-reactive protein level also were associated with higher short- and long-term MACEs. Use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), and statins was associated with decreased risk of MACEs. Limitations: Single assessment of serum creatinine. Conclusion: eGFR was associated independently with mortality and complications after AMI. PCI, β-blocker, ACE inhibitor or ARB, and statin use were associated with decreased risks of short- and long-term MACEs.
KW - Acute myocardial infarction
KW - glomerular filtration rate
KW - major adverse cardiac event
UR - http://www.scopus.com/inward/record.url?scp=84862797441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862797441&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2012.01.016
DO - 10.1053/j.ajkd.2012.01.016
M3 - Article
VL - 59
SP - 795
EP - 802
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
SN - 0272-6386
IS - 6
ER -